626
Views
7
CrossRef citations to date
0
Altmetric
Review

Abdominal obesity and metabolic syndrome in South Asians: prevention and management

, ORCID Icon &
Pages 339-349 | Received 27 Jul 2021, Accepted 15 Sep 2021, Published online: 29 Sep 2021

References

  • James I Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). 2001.
  • Park Y-W, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988–1994. Arch Internal Med. 2003;163(4):427–436.
  • Ogurtsova K, da Rocha Fernandes J, Huang Y, et al. IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
  • World Health Organization. Noncommunicable diseases country profiles 2018. 2018. https://apps.who.int/iris/handle/10665/274512.
  • Grundy SM. Obesity, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab. 2004;89(6):2595–2600.
  • Carmienke S, Freitag M, Pischon T, et al. General and abdominal obesity parameters and their combination in relation to mortality: a systematic review and meta-regression analysis. Eur J Clin Nutr. 2013;67(6):573–585.
  • J-p D, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881–887.
  • Castro AVB, Kolka CM, Kim SP, et al. Obesity, insulin resistance and comorbidities? Mechanisms of association. Arquivos Brasileiros De Endocrinologia & Metabologia. 2014;58(6):600–609.
  • Neeland IJ, Ayers CR, Rohatgi AK, et al. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults. Obesity. 2013;21(9):E439–E447.
  • Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–819.
  • Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome. Circulation. 2005;112(17):2735–2740.
  • Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32(1):76–88.
  • Abete I, Astrup A, Martínez JA, et al. Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr Rev. 2010;68(4):214–231.
  • Panagiotakos DB, Pitsavos C, Chrysohoou C, et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J. 2004;147(1):106–112.
  • Pattyn N, Cornelissen VA, Eshghi SRT, et al. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome. Sports Med. 2013;43(2):121–133.
  • Lear SA, Ethnicity GD. Metabolic syndrome: implications for assessment, management and prevention. Nutrients. 2019;12(1):15.
  • Lear SA, Gasevic D. Ethnicity and metabolic syndrome: implications for assessment, management and prevention. Nutrients. 2020;12(1):15.
  • Misra A, Khurana L. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention. Metab Syndr Relat Disord. 2009 Dec;7(6):497–514.
  • Turin TC, Shahana N, Wangchuk LZ, et al. Burden of cardio-and cerebro-vascular diseases and the conventional risk factors in South Asian population. Glob Heart. 2013;8(2):121–130.
  • Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the US. Diabetes Care. 2005;28(11):2745–2749.
  • Cleeman J, Grundy S, Becker D, et al. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Adult Treatment Panel (ATP III). Jama. 2001;285(19):2486–2497.
  • Moy FM, Bulgiba A. The modified NCEP ATP III criteria maybe better than the IDF criteria in diagnosing metabolic syndrome among Malays in Kuala Lumpur. BMC Public Health. 2010;10(1):1–6.
  • Takamiya T, Zaky WR, Edmundowics D, et al. World Health Organization-defined metabolic syndrome is a better predictor of coronary calcium than the adult treatment panel III criteria in American men aged 40–49 years. Diabetes Care. 2004;27(12):2977–2979.
  • Bhowmik B, Afsana F, Siddiquee T, et al. Comparison of the prevalence of metabolic syndrome and its association with diabetes and cardiovascular disease in the rural population of Bangladesh using the modified National Cholesterol Education Program Expert Panel Adult Treatment Panel III and International Diabetes Federation definitions. J Diabetes Investig. 2015;6(3):280–288.
  • Mehata S, Shrestha N, Mehta RK, et al. Prevalence of the metabolic syndrome and its determinants among Nepalese adults: findings from a nationally representative cross-sectional study. Sci Rep. 2018 Oct;8.
  • Katulanda P, Ranasinghe P, Jayawardana R, et al., Metabolic syndrome among Sri Lankan adults: prevalence, patterns and correlates. Diabetol Metab Syndr. 2012;4(1):1–10.
  • Iqbal Hydrie MZ, Shera AS, Fawwad A, et al. Prevalence of metabolic syndrome in urban Pakistan (Karachi): comparison of newly proposed International Diabetes Federation and modified adult treatment panel III criteria. Metab Syndr Relat Disord. 2009;7(2):119–124.
  • Ravikiran M, Bhansali A, RaviKumar P, et al. Prevalence and risk factors of metabolic syndrome among Asian Indians: a community survey. Diabetes Res Clin Pract. 2010[2010 Aug 01];89(2):181–188.
  • Mehata S, Shrestha N, Mehta RK, et al. Prevalence of the metabolic syndrome and its determinants among Nepalese adults: findings from a nationally representative cross-sectional study. Sci Rep. 2018 Oct 9;8(1):14995.
  • Aryal N, Wasti SP. The prevalence of metabolic syndrome in South Asia: a systematic review.Int J Diabetes Dev Ctries. 2016[2016 Sept 01];36(3):255–262.
  • Saeed K, Rasooly M, Alkozai A. Prevalence of risk factors for noncommunicable diseases in Jalalabad city, Afghanistan, evaluated using the WHO STEPwise approach. East Mediterr Health J. 2016;21(11):783–790.
  • Zaman MM, Rahman MM, Rahman MR, et al. Prevalence of risk factors for non-communicable diseases in Bangladesh: results from STEPS survey 2010. Indian J Public Health. 2016 Jan-Mar;60(1):17–25.
  • Sarma PS, Sadanandan R, Thulaseedharan JV, et al. Prevalence of risk factors of non-communicable diseases in Kerala, India: results of a cross-sectional study. BMJ Open. 2019 Nov 10;9(11):e027880.
  • Aboobakur M, Latheef A, Mohamed AJ, et al. Surveillance for non-communicable disease risk factors in Maldives: results from the first STEPS survey in Male. Int J Public Health. 2010;55(5):489–496.
  • Basit A, Askari S, Zafar J, et al. NDSP 06: prevalence and risk factors for obesity in urban and rural areas of Pakistan: a study from second National Diabetes Survey of Pakistan (NDSP), 2016–2017. Obes Res Clin Pract. 2021;15(1):19–25.
  • Katulanda P, Jayawardena M, Sheriff M, et al. Prevalence of overweight and obesity in Sri Lankan adults. Obesity Rev. 2010;11(11):751–756.
  • Nammi S, Koka S, Chinnala KM, et al. Obesity: an overview on its current perspectives and treatment options. Nutr J. 2004;3(1):1–8.
  • Misra A, Khurana L. Obesity-related non-communicable diseases: south Asians vs White Caucasians. Int J Obes. 2011;35(2):167–187.
  • Enas E, Kannan S. How to beat the heart disease epidemic among South Asians. A prevention and management guide for Asian Indians and their doctors. downers grove: advanced heart lipid clinic USA, 2007. Indian Heart J. 2008;60:161–175.
  • Alberti K, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. 2009;120(16):1640–1645.
  • Chandalia M, Lin P, Seenivasan T, et al. Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PLoS One. 2007;2(8):e812.
  • Jayawardena R, Hills AP. Body composition derived body mass index and waist circumference cut-offs for Sri Lankan adults. Obes Med. 2020;18:100214.
  • Misra A, Bhardwaj S. Obesity and the metabolic syndrome in developing countries: focus on South Asians. In: International nutrition: achieving millennium goals and beyond. Vol. 78. Karger Publishers; 2014. p. 133–140.
  • Prasad DS, Kabir Z, Dash AK, et al. Prevalence and risk factors for metabolic syndrome in Asian Indians: a community study from urban Eastern India. J Cardiovasc Dis Res. 2012 Jul;3(3):204–211.
  • Kaur J. Assessment and screening of the risk factors in metabolic syndrome. Med Sci. 2014;2:3.
  • Verma P, Srivastava RK, Jain D. Association of lifestyle risk factors with metabolic syndrome components: a cross-sectional study in Eastern India. Int J Prev Med. 2018;9:6.
  • Wijesinghe N. Metabolic Syndrome among South Asians. J Ceylon Coll Physic. 2018;49:2.
  • Rathnayake KM, Roopasingam T, Dibley MJ. High carbohydrate diet and physical inactivity associated with central obesity among premenopausal housewives in Sri Lanka.BMC Res Notes. 2014[2014 Aug 23];7(1):564.
  • Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390(10107):2050–2062.
  • Volek JS, Fernandez ML, Feinman RD, et al. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res. 2008[2008 Sept 01];47(5):307–318.
  • Liu S, Willett WC. Dietary glycemic load and atherothrombotic risk. Curr Atheroscler Rep. 2002;4(6):454–461.
  • Liu S, Manson JE. Dietary carbohydrates, physical inactivity, obesity, and the ‘metabolic syndrome’ as predictors of coronary heart disease. Curr Opin Lipidol. 2001;12:4.
  • Ozougwu J, Obimba K, Belonwu C, et al. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4(4):46–57.
  • Dyson PA. The therapeutics of lifestyle management on obesity. Diabetes Obesity Metab. 2010;12(11):941–946.
  • Oldridge NB, Stump TE, Nothwehr FK, et al. Prevalence and outcomes of comorbid metabolic and cardiovascular conditions in middle-and older-age adults. J Clin Epidemiol. 2001;54(9):928–934.
  • Gómez-Ambrosi J, Catalán V, Rodríguez A, et al. Increased cardiometabolic risk factors and inflammation in adipose tissue in obese subjects classified as metabolically healthy. Diabetes Care. 2014;37(10):2813–2821.
  • Blüher M, Mantzoros CS. From leptin to other adipokines in health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131–145.
  • Scheid MP, Sweeney G. The role of adiponectin signaling in metabolic syndrome and cancer. Rev Endocr Metab Disord. 2014;15(2):157–167.
  • Vega GL, Grundy SM. Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes. 2013;2013.
  • Frühbeck G, GÓMEZ‐AMBROSI J, Salvador J. Leptin‐induced lipolysis opposes the tonic inhibition of endogenous adenosine in white adipocytes. FASEB J. 2001;15(2):333–340.
  • Iliodromiti S, Ghouri N, Celis-Morales CA, et al. Should physical activity recommendations for South Asian adults be ethnicity-specific? Evidence from a cross-sectional study of South Asian and White European Men And Women. PLoS One. 2016;11(8):e0160024–e0160024.
  • Ranasinghe C, Devage S, Constantine GR, et al. Glycemic and cardiometabolic effects of exercise in South Asian Sri Lankans with type 2 diabetes mellitus: a randomized controlled trial Sri Lanka diabetes aerobic and resistance training study (SL-DARTS). Diabetes Metab Syndr. 2021;15(1):77–85.
  • Venkatasamy VV, Pericherla S, Manthuruthil S, et al. Effect of physical activity on insulin resistance, inflammation and oxidative stress in diabetes mellitus. J Clin Diagn Res. 2013;7(8):1764.
  • Strasser B. Physical activity in obesity and metabolic syndrome. Ann N Y Acad Sci. 2013;1281(1):141.
  • Ross R. Does exercise without weight loss improve insulin sensitivity? Diabetes Care. 2003;26(3):944–945.
  • Misra A, Soares MJ, Mohan V, et al. Body fat, metabolic syndrome and hyperglycemia in South Asians. J Diabetes Complications. 2018 Nov;32(11):1068–1075.
  • Misra A, Jayawardena R, Anoop S. Obesity in South Asia: phenotype, morbidities, and mitigation. Curr Obes Rep. 2019 Mar;8(1):43–52.
  • Misra A, Vikram NK. Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition. 2003 May;19(5):457–466.
  • Misra A, Anoop S, Gulati S, et al. Body fat patterning, hepatic fat and pancreatic volume of non-obese Asian Indians with type 2 diabetes in North India: a case-control study. PLoS One. 2015;10(10):e0140447.
  • Gulati S, Misra A. Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake. Eur J Clin Nutr. 2017 Jul;71(7):850–857.
  • Yadav R, Yadav RK, Khadgawat R, et al. Comparative efficacy of a 12 week yoga-based lifestyle intervention and dietary intervention on adipokines, inflammation, and oxidative stress in adults with metabolic syndrome: a randomized controlled trial. Transl Behav Med. 2019 Jul 16;9(4):594–604.
  • Gulati S, Misra A, Pandey RM, et al. Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial. Nutrition. 2014;30(2):192–197.
  • Jain SG, Puri S, Misra A, et al. Effect of oral cinnamon intervention on metabolic profile and body composition of Asian Indians with metabolic syndrome: a randomized double-blind control trial. Lipids Health Dis. 2017;16(1):1–11.
  • Andersen E, Høstmark AT, Anderssen SA. Effect of a physical activity intervention on the metabolic syndrome in Pakistani immigrant men: a randomized controlled trial.J Immigr Minor Health. 2012[2012 Oct 01];14(5):738–746.
  • Telle-Hjellset V, MKR K, Bjørge B, et al. The InnvaDiab-DE-PLAN study: a randomised controlled trial with a culturally adapted education programme improved the risk profile for type 2 diabetes in Pakistani immigrant women. Br J Nutr. 2013;109(3):529–538.
  • Amin F, Islam N, Anila N, et al. Clinical efficacy of the co-administration of turmeric and black seeds (Kalongi) in metabolic syndrome – a double blind randomized controlled trial – TAK-MetS trial. Complement Ther Med. 2015[2015 Apr 01];23(2):165–174.
  • Radhakrishnan J, Swaminathan N, Pereira N, et al. Effect of an IT-supported home-based exercise programme on metabolic syndrome in India. J Telemed Telecare. 2014;20(5):250–258.
  • Admiraal WM, Vlaar EM, Nierkens V, et al. Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18 to 60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One. 2013;8(7):e68605.
  • Najmi A, Nasiruddin M, Khan RA, et al. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev Ctries. 2008 Jan;28(1):11–14.
  • Choudhary PR, Jani RD, Sharma MS. Effect of raw crushed garlic (Allium sativum L.) on components of metabolic syndrome [article]. J Dietary Suppl. 2018;15(4):499–506.
  • Kousar R, Burns C, Lewandowski P. A culturally appropriate diet and lifestyle intervention can successfully treat the components of metabolic syndrome in female Pakistani immigrants residing in Melbourne, Australia.Metabolism. 2008[2008 Nov 01];57(11):1502–1508.
  • Shrivastava U, Fatma M, Mohan S, et al. Randomized control trial for reduction of body weight, body fat patterning, and cardiometabolic risk factors in overweight worksite employees in Delhi, India. J Diabetes Res. 2017[2017Nov 29];2017:7254174.
  • Khan A, Bryden NA, Polansky MM, et al. Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res. 1990;24(2):183–188.
  • Hosseini A, Hosseinzadeh H. A review on the effects of Allium sativum (Garlic) in metabolic syndrome. J Endocrinol Invest. 2015;38(11):1147–1157.
  • Sivasankaran S. The cardio-protective diet. Indian J Med Res. 2010;132(5):608.
  • Weerahewa J, Rajapakse C, Pushpakumara G. An analysis of consumer demand for fruits in Sri Lanka. 1981–2010. Appetite. 2013 Jan;60(1):252–258.
  • Jayawardena R, Sooriyaarachchi P, Punchihewa P, et al. Effects of “plate model” as a part of dietary intervention for rehabilitation following myocardial infarction: a randomized controlled trial. Cardiovasc Diagn Ther. 2019;9(2):179–188.
  • Jayawardena R, Swarnamali H, Ranasinghe P, et al. Impact of portion-control plates (PCP) on weight reduction: a systematic review and meta-analysis of intervention studies. Obes Res Clin Pract. 2021;15(2):106–113.
  • Kehoe SH, Dhurde V, Bhaise S, et al. Barriers and facilitators to fruit and vegetable consumption among rural Indian women of reproductive age. Food Nutr Bull. 2019;40(1):87–98.
  • Choudhury S, Shankar B, Aleksandrowicz L, et al. What underlies inadequate and unequal fruit and vegetable consumption in India? An exploratory analysis. Global Food Secur. 2020[2020 Mar 01];24:100332.
  • Cunningham SA, Shaikh NI, Datar A, et al. Food subsidies, nutrition transition, and dietary patterns in a remote Indian district. Global Food Secur. 2021[2021 Jun 01];29:100506.
  • Rathnayake KM, Satchithananthan A, Mahamithawa S, et al. Early life predictors of preschool overweight and obesity: a case–control study in Sri Lanka. BMC Public Health. 2013;13(1):1–6.
  • Winichagoon P. Transition of maternal and child nutrition in Asia: implications for public health. Curr Opin Clin Nutr Metab Care. 2015;18(3):312–317.
  • Anjana RM, Pradeepa R, Das AK, et al. Physical activity and inactivity patterns in India - results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. Int J Behav Nutr Phys Act. 2014;11(1):26.
  • Misra A, Chowbey P, Makkar B, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. Japi. 2009;57(2):163–170.
  • Escalante Y, García-Hermoso A, Backx K, et al. Playground designs to increase physical activity levels during school recess: a systematic review. Health Educ Behav. 2014;41(2):138–144.
  • Tarun S, Arora M, Rawal T, et al. An evaluation of outdoor school environments to promote physical activity in Delhi, India. BMC Public Health. 2017[2017 Jan 05];17(1):11.
  • Senarath U, Katulanda P, Fernando DN, et al. mHealth nutrition and lifestyle intervention (mHENAL) to reduce cardiovascular disease risk in a middle-aged, overweight and obese population in Sri Lanka: study protocol for a randomized controlled trial. Contemp Clin Trials Commun. 2019;16:100453.
  • Iyer A, Panchal S, Poudyal H, et al. Potential health benefits of Indian spices in the symptoms of the metabolic syndrome: a review. Indian J Biochem Biophys. 2009 Dec;46(6):467–481.
  • Ranasinghe P, Jayawardana R, Galappaththy P, et al., Efficacy and safety of ‘true’cinnamon (Cinnamomum zeylanicum) as a pharmaceutical agent in diabetes: a systematic review and meta‐analysis. Diabetic Med. 2012;29(12):1480–1492.
  • Ranasinghe P, Galappaththy P, Constantine GR, et al. Cinnamomum zeylanicum (Ceylon cinnamon) as a potential pharmaceutical agent for type-2 diabetes mellitus: study protocol for a randomized controlled trial. Trials. 2017;18(1):1–8.
  • Jayawardena R, Ranasinghe P, Chathuranga T, et al. The benefits of yoga practice compared to physical exercise in the management of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Metab Syndr. 2018 Sep;12(5):795–805.
  • Jayawardena R, Ranasinghe P, Ranawaka H, et al. Exploring the therapeutic benefits of Pranayama (Yogic Breathing): a systematic review. Int J Yoga. 2020 May-Aug;13(2):99–110.
  • Sooriyaarachchi P, Jayawardena R, Pavey T, et al. Shift work and body composition: a systematic review and meta-analysis. Minerva Endocrinol. 2021; DOI:https://doi.org/10.23736/S2724-6507.21.03534-X.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.